JPRN-jRCT2080220611未知1 期
Phase I Study of Satraplatin Plus Prednisolone in Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated with a Docetaxel-based Regimen
试验速览
- 阶段
- 1 期
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Male
入选标准
- •(1)Patients who are histologically or cytologically proven prostate cancer
- •(2)Patients who meet the diagnostic criteria of stage D2 metastatic prostate cancer
- •(3)Patients who are progressive after one docetaxel-based regimen for metastatic prostate cancer
- •(4)ECOG performance status (PS) :0-2
排除标准
- •(1)Patients who have received more than one prior chemotherapy regimen for metastatic disease
- •(2)Patients who have received any chemotherapy within 21 days prior to registration
- •(3)Patients who have a serious concurrent uncontrolled medical disorder
- •(4)Patients with a known history of brain metastases
研究者
相似试验
进行中（未招募）
不适用
A Phase 2 Study comparing sequential satraplatin and erlotinib to single-agent erlotinib in patients >70 years of age with unresectable stage 3 or 4 Non-small Cell Lung Cancer as 1st-line therapy - satraplatin+erlotinib NSCLC pts > 70 yrs 1st linePatients > 70 years of age with locally advanced or unresectable stage III-IV NSCLC, with no prior sistemic treatment for metastatic disease.MedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2006-001973-10-ITGPC BIOTECH120
进行中（未招募）
不适用
A Phase 2 study comparing sequential satraplatin and erlotinib to single-agent erlotinib in patients >/= 70 years of age with unresectable stage 3 or 4 non-small cell lung cancer as 1st -line therapyPatients of at least 70 Years of Age with unresectable Stage 3 or 4 Non-Small Cell Lung Cancer. For further explanation see Inclusion (E.3) / Exclusion Criteria (E.4).EUCTR2006-001973-10-NLGPC Biotech AG120
已完成
1 期
Phase I study of S-1 plus cisplatin and intraperitoneal administration of paclitaxel for gastric cacner with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000013528agoya University9
已完成
2 期
Satraplatin and Prednisone to Treat Prostate CancerGenetic PolymorphismProstate CancerNCT00634647National Cancer Institute (NCI)24
招募中
1 期
Phase I/II trial of Nedaplatin/S-1 combination followed by maintenance S-1 therapy in advanced Squamous Cell Lung CancerJPRN-UMIN000009399Department of Medical Oncology, Kinki University Faculty of Medicine25